Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Yeganeh Reuven. Officer active across 2 companies, notably Nukkleus Inc.. Aggregated, 4 filings have been published. Activity tracked since 16 December 2024. The latest transaction was disclosed on 16 March 2026 (C). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Yeganeh Reuven is a director at BiomX Inc. (XNAS) and Nukkleus Inc. (XNAS). The declarant has 4 filings in total, and, across the sampled recent filings from 2024-12-20 to 2026-03-18, both the buy and sell amounts are 0 EUR.